NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

與COVID-19相關的臨床試驗,遠程醫療,疫苗和其他市場(修訂版)

COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets

出版商 Kalorama Information 商品編碼 984999
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
與COVID-19相關的臨床試驗,遠程醫療,疫苗和其他市場(修訂版) COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets
出版日期: 2020年11月02日內容資訊: 英文
簡介

本報告研究了與COVID-19相關的臨床試驗,遠程醫療,疫苗和其他市場的最新信息,包括市場概況,分子診斷/抗原和抗體檢測/疫苗的市場變化等。我們提供以下信息:類型和地區。

目錄

第1章執行摘要

  • 概述
    • COVID-19總計
    • 主要國家/地區:每7天平均COVID病例數變化(每百萬人)
    • COVID-19測試
  • 範圍和方法調查方法

第2章COVD-19診斷

  • 臨床檢查狀況
    • 眾多批准
  • FDA批准的檢查
    • 分子
    • 免疫學檢查
  • 改變情況的COVID-19抗原檢測測試
    • COVID-19市場
  • COVID-19測試開發
    • COVID-19,影響了LDT市場
    • 緊急醫療中心和COVID-19測試
    • 各種SARS-CoV-2抗體試劑盒的準確性
    • 在COVID-19 "Nudge" 測試的臨床研究中很有希望
    • 高度敏感的基於CRISPR的新COVID-19測試等
  • 產品開發
    • NIH,BARDA:根據COVID-19合同獲得9835萬美元
    • 新的COVIDNGS檢查
    • 提示:為COVID-19測試獲得DOD資助
    • Beckman Coulter:COVID-19 IgM分析
    • GenMark:多重測試等。
  • 新法規
    • 對於COVID-19測試重要的LDT由AACC

第3章遠程醫療

  • COVID-19對遠程醫療的影響
    • COVID-19的要點
    • RPM/遠程醫療市場表現
  • 企業績效
    • ABBOTT
    • AMERICAN WELL (AMWELL)
    • ASCOM HOLDING AG
    • BRIGHT.MD
    • DOCTOR ON DEMAND
    • EKO DEVICES
    • G MEDICAL INNOVATIONS HOLDING LTD.
    • GENERAL DEVICES
    • GLOOKO
    • MASIMO
    • MEDTRONIC
    • OSI SYSTEMS
    • PHILIPS - KONINKLIJKE PHILIPS N.V. (ROYAL PHILIPS)
    • TELADOC HEALTH
    • THINKLABS
    • TYTOCARE

第4章COVID-19和生命科學調查

  • 關閉調查室並否認身份
  • COVID-19調查和出版物
  • COVID-19用於治療開發的研究抗體
  • 生命科學工具市場注意事項

第5章疫苗

  • 美國成年人如何接受COVID-19疫苗
  • 通用冠狀病毒疫苗?
    • Moderna:來自中東/非洲的批准並提交營銷批准
目錄
Product Code: 20-036

COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic.

Particular sections address the most important market changes:

  • Molecular Diagnostics: COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.
  • Antigen and Antibody Tests: Never have immunoassays been of such worldwide attention, as antibody tests are greatly sought. With this, come concerns about accuracy levels on broad populations and greater knowledge about development times. There are now immunoassays in development. We track these efforts and provide commentary on the role of these tests in a threat so far dominated by molecular diagnostics.
  • Vaccines: We look at the vaccines in development and the struggles with vaccine discovery and manufacturing in other pandemics.
  • Life Science Research - what are the trends in experiments and publications, how has COVID-19 affected lab research volume and tools markets.
  • Remote Patient Monitoring: Already a healthcare trend that was catching on but perhaps struggling to convince payors of its critical necessity, remote patient monitoring and telehealth transformed overnight with social distancing policies and relaxed HIPAA rules. Kalorama has contacted a number of companies for October 2020 updates.

As part of this report's offerings, the following information is included:

  • Market for COVID-19 by Type: PCR, Antigen, Antibody
  • Market for COVID-19 by Region: US, Europe, Asia, ROW
  • Current EUA Test Approvals
  • Antigen COVID-19 Tests
  • Overall Clinical Lab Volume Trends (April to September)
  • Market for Telehealth and COVID-19 Impact
  • Telehealth Company Responses to COVID-19
  • COVID-19 Vaccines in Development
  • COVID-19 Vaccine Pre Sales

This report does not seek to provide a data-driven market assessment due to the rapidly-changing situation, but does provide analyst commentary that may assist customers needing to work out models. Some of Kalorama Information's market estimates provide foundational bases on which to judge potential market impact.

Commentary and analysis from Kalorama authors who have studied markets in some cases for decades add understanding to the current, often chaotic, market atmosphere. Further publications and surveys from Kalorama Information will provide additional market impact data.

Companies Discussed Include:

  • Abbott
  • American Well (Amwell)
  • Ascom Holding
  • Astra Zeneca
  • Beckman Coulter
  • Becton Dickinson
  • Bright.Md
  • Cepheid
  • Cue Health
  • Doctor On Demand
  • Eko Devices
  • Eurofins
  • G Medical Innovations Holding Ltd.
  • General Devices
  • Genmark
  • Hologic
  • Johnson and Johnson
  • Medtronic
  • Moderna
  • Philips
  • Qiagen
  • Quidel
  • Roche
  • Teladoc Health

TABLE OF CONTENTS

CHAPTER 1: EXECUTIVE SUMMARY

  • OVERVIEW
    • COVID-19 Cases Total
    • COVID Cases Rolling 7-Day Average Per Million by Major Countries
    • COVID-19 TESTING
  • SCOPE AND METHODOLOGY

CHAPTER 2: COVD-19 DIAGNOSTICS

  • CLINICAL LAB SITUATION
    • Table: Clinical Labs Percent of Labs Experiencing Volume Declines Due to COVID-19 and Shutdowns [Major, Minor, No Decline]
    • Large Number of Approvals
  • TEST APPROVED BY FDA
    • Molecular
    • Immunoassays
      • Table: Tests for COVID-19 Authorized by FDA
  • ANTIGENT TESTS CHANGE COVID-19 LANDSCAPE
    • COVID-19 MARKET
      • Figure : IVD COVID-19 Market, Distribution by Region (North America, Europe, Asia Pacific, RoW), 2020 % KOREAN COVID-19 TESTING FOCUS
  • COVID-19 TESTING DEVELOPMENTS
    • COVID Driving LDT Market
    • CMS Seeks to Spur Speed of Results by Cutting Fees for Slower Labs
    • Urgent care Centers and COVID-19 testing
    • Study finds SARS-CoV-2 antibody kits have varying accuracy
    • COVID-19 "Nudge" Test shows promise in clinical study
    • New CRISPR-based COVID-19 test shows high sensitivity
    • Blood test score helps predict COVID-19 severity
    • Biomarkers to determine COVID-19 odds: GW researchers
  • PRODUCT DEVELOPMENTS
    • NIH, BARDA award $98.35M in COVID-19 Contracts
    • New COVID NGS Test
    • Cue secures DOD Grant for COVID-19 tests
    • Beckman Coulter COVID-19 IgM assay
    • GenMark Multiplex test
    • 20/20 takes orders for 1st POC Fingerstick COVID-19 test
    • Quidel gets EUA for Combo flu, COVID-19 test
    • Biocept reaches COVID-19 testing milestone
    • LabCorp nabs EUA for new COVID-19 molecular test
    • FDA issues EUA for OralDNA's oral rinse COVID-19 test
    • LDTs AND COVID-19
  • NEW LEGISLATION
    • LDTs Critical for COVID-19 Testing, Says AACC

CHAPTER 3: TELEHEALTH

  • COVID-19 IMPACT ON TELEHALTH: KEY TAKEAWAYS
    • COVID-19 Key Takeaways
    • RPM/Telehealth Market Performance
  • COMPANY RESULTS
    • ABBOTT
    • AMERICAN WELL (AMWELL)
    • ASCOM HOLDING AG
    • BRIGHT.MD
    • DOCTOR ON DEMAND
    • EKO DEVICES
    • G MEDICAL INNOVATIONS HOLDING LTD.
    • GENERAL DEVICES
    • GLOOKO
    • MASIMO
    • MEDTRONIC
    • OSI SYSTEMS
    • PHILIPS - KONINKLIJKE PHILIPS N.V. (ROYAL PHILIPS)
    • TELADOC HEALTH
    • THINKLABS
    • TYTOCARE

CHAPTER 4. COVID-19 AND LIFE SCIENCE RESEARCH

  • RESEARCH LAB SHUTDOWN AND DECLINE STATUS
  • COVID-19 RESEARCH AND PUBLICATIONS
  • SHINING A SPOTLIGHT IN A CHALLENGED MARKET: RESEARCH ANTIBODIES FOR COVID-19 THERAPEUTIC DEVELOPMENT
  • LIFE SCIENCE TOOLS MARKET CONSIDERATIONS

CHAPTER 5. VACCINES

  • Figure: COVID-19 Per Capita Doses Ordered by Country
  • Figure: COVID-19 Vaccine Candidates: Government Presales
  • HOW WILLING ARE U.S. ADULTS TO ACCEPT A COVID-19 VACCINE?
  • UNIVERSAL CORONAVIRUS VACCINES?
    • Moderna gets nod from EMA to submit marketing authorization